z-logo
open-access-imgOpen Access
Outcomes of Chemotherapy for Microsatellite Instable–High Metastatic Colorectal Cancers
Author(s) -
Katerina Shulman,
Ofra BarnettGriness,
Vered Friedman,
Joel K. Greenson,
Stephen B. Gruber,
Flavio Lejbkowicz,
Gad Rennert
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.17.00253
Subject(s) - medicine , bevacizumab , colorectal cancer , oncology , hazard ratio , microsatellite instability , chemotherapy , population , cancer , gastroenterology , microsatellite , allele , biology , confidence interval , biochemistry , environmental health , gene
Microsatellite instable-high (MSI-H) colorectal cancers (CRCs) are known to carry better survival in the local disease stage even without treatment. The influence of types of treatment on survival of MSI-H metastatic CRCs (mCRCs) is still unclear and is evaluated in this study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here